IntegraDose Compounding Services LLC: Drug Recall

Recall #D-0015-2026 · 09/16/2025

Class I: Dangerous

Recall Details

Recall Number: D-0015-2026
Classification: Class I
Product Type: Drug
Recalling Firm: IntegraDose Compounding Services LLC
Status: Ongoing
Date Initiated: 09/16/2025
Location: Minneapolis, MN, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 853/500 mL bags

Reason for Recall

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

Product Description

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

Distribution Pattern

Nationwide in the USA

Other Recalls by IntegraDose Compounding Services LLC

Class II: Risk 03/22/2024

Lack of Assurance of Sterility: leaking bags
Class II: Risk 01/22/2024

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Class II: Risk 01/12/2024

Subpotent Drug
Class II: Risk 09/17/2021

Lack of sterility assurance.
Class II: Risk 09/17/2021

Lack of sterility assurance.

View all recalls by IntegraDose Compounding Services LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.